MIRM - Mirum Pharmaceuticals, Inc.

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 41.12

Open

Bid

$ 41.06 x 100

Ask

$ 41.17 x 148

Day's Range

-- - --

52 Week Range

$ 23.14 - $ 45.23

Volume

295,349

Average Volume

Market Cap

1.96B

Beta (5Y Monthly)

$ 1.02

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	03-15-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-07-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	03-08-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	03-09-2022	12-31-2021	10-K
12	11-15-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-09-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	03-12-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-28-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Maintains Overweight on ...
08/08/2024 14:46:30

Cantor Fitzgerald analyst Josh Schimmer maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price...

Evercore ISI Group Maintains Outperform on...
08/08/2024 13:10:12

Evercore ISI Group analyst Gavin Clark-Gartner maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Outperform and raises th...

Baird Maintains Outperform on Mirum Pharma...
08/08/2024 11:59:05

Baird analyst Brian Skorney maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Outperform and raises the price target from...

Mirum Pharmaceuticals On Track To Achieve ...
08/07/2024 21:31:23

Mirum Pharmaceuticals Q2 2024 GAAP EPS $(0...
08/07/2024 20:20:50

Mirum Pharmaceuticals (NASDAQ:MIRM) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate ...

Watching Mirum Pharmaceuticals; Shares Tra...
07/26/2024 19:19:44

HC Wainwright & Co. Reiterates Buy on Miru...
07/26/2024 11:20:09

HC Wainwright & Co. analyst Ed Arce reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and maintains $66 price ta...

Mirum's LIVMARLI Now Approved For Progress...
07/25/2024 12:33:20

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved a label...

Janus Henderson Group Discloses 10.6% Pass...
07/10/2024 17:18:09

- Form 13G

HC Wainwright & Co. Reiterates Buy on Miru...
07/08/2024 17:54:19

HC Wainwright & Co. analyst Ed Arce reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and maintains $66 price ta...

Mirum Pharmaceuticals' LIVMARLI Approved I...
07/08/2024 12:38:45

European Commission grants LIVMARLI marketing authorization for treatment of PFIC in patients three months and older.Approval f...

HC Wainwright & Co. Reiterates Buy on Miru...
06/28/2024 17:26:22

HC Wainwright & Co. analyst Ed Arce reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and maintains $66 price ta...

Mirum Submits New Drug Application To FDA ...
06/28/2024 12:36:22

Submission based on the positive Phase 3 RESTORE studyMirum holds orphan designation for chenodiol in CTXPotential to have firs...

Stifel Maintains Buy on Mirum Pharmaceutic...
06/20/2024 13:22:57

Stifel analyst Dae Gon Ha maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and raises the price target from $48 to $66.

Citigroup Maintains Buy on Mirum Pharmaceu...
06/18/2024 14:43:01

Citigroup analyst David Lebowitz maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and raises the price target from $...

JP Morgan Maintains Overweight on Mirum Ph...
06/18/2024 14:09:38

JP Morgan analyst Jessica Fye maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price target fr...

nvidia-to-rally-around-53-here-are-10-top-analyst-forecasts-for-tuesday

Nvidia To Rally Around 53%? Here Are 10 To...
06/18/2024 13:44:27

Morgan Stanley Maintains Overweight on Mir...
06/18/2024 11:08:58

Morgan Stanley analyst Michael Ulz maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price targ...

JMP Securities Maintains Market Outperform...
06/18/2024 10:53:09

JMP Securities analyst Jonathan Wolleben maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Market Outperform and raises t...

why-ovid-therapeutics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Ovid Therapeutics Shares Are Trading L...
06/17/2024 17:21:47